3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
12
Non-Muscle Invasive Bladder Neoplasms
9
Carcinoma, Transitional Cell
7
Stomach Neoplasms
4
Anus Neoplasms
4
Pancreatic Neoplasms
3
Carcinoma, Hepatocellular
3
Peritoneal Neoplasms
2
Liver Neoplasms
2
Colorectal Neoplasms
2
Appendiceal Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pseudomyxoma Peritonei
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Mycobacterium Infections
1
Gastrointestinal Neoplasms
1
Dermatitis
1
Carcinoma in Situ
1
Carcinoma
1
Anal Canal Carcinoma
1
Adenocarcinoma
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
Mitomycin
×
Clear all
No trials found.